Home » Thought Leadership » Blogs » Interview Series with Leaders …

Interview Series with Leaders of DTx: Challenges & Opportunities for Commercialization

April 14, 2021


Written by: Patrick Buck

In this interview series, CBPartners’ Digital Therapeutics & Health Technology Expertise Team speak to some of the leaders of the digital therapeutics (DTx) space to collect their thoughts on the current challenges and opportunities for DTx commercialization.

Joseph Perekupka – Chief Commercial Officer of Freespira

Freespira is the only FDA-cleared digital therapeutic proven to significantly reduce or eliminate symptoms of panic attacks, panic disorder, and post-traumatic stress disorder (PTSD) in just 28 days by training users to normalize respiratory irregularities.

Release Date: April 14, 2021   |   Read the Interview Here


Owen McCarthy – President & Co-Founder of MedRhythms 

MedRhythms is developing evidence-based, FDA-regulated devices to treat, manage, and diagnose neurologic injuries and diseases. 

Release Date: April 28, 2021   |   Read the Interview Here



Ofer Leidner DTx leaderOfer Leidner – Co-Founder & President of Happify Health

Happify Health is a global healthcare platform that combines digital therapeutics and care delivery solutions to improve mental health, physical health, & well-being.

Release Date: May 12, 2021  |   Read the Interview Here




If you are interested in reading more about the digital therapeutics landscape, read related posts in the expertise team’s thought leadership channel.